Table 3 Summary of univariate and multivariate Cox regression analysis of overall survival duration
From: Decreased expression of LATS1 is correlated with the progression and prognosis of glioma
Parameter | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
P | HR | 95%CI | P | HR | 95%CI | |
Age | ||||||
≥55vs. <55 years | 0.069 | 0.777 | 0.593-1.019 |  |  |  |
Gender | ||||||
Male vs. female | 0.160 | 0.820 | 0.621-1.082 | Â | Â | Â |
WHO grade | ||||||
Ivs.II vs.III vs.IV | 0.000 | 1.715 | 1.454-2.023 | 0.000 | 1.463 | 1.233-1.735 |
KPS | ||||||
≥80 vs. < 80 | 0.000 | 2.033 | 1.540-2.684 | 0.000 | 2.437 | 1.810-3.283 |
LAST1 expression | Â | Â | Â | Â | Â | Â |
Strong vs.Positive vs.Weak vs.Negative* | 0.000 | 0.437 | 0.362-0.528 | 0.000 | 0.389 | 0.316-0.478 |